Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance
- PMID: 8414019
- DOI: 10.1212/wnl.43.9.1715
Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance
Abstract
We measured serum antibodies to botulinum toxin (ABT) in 96 patients with focal dystonia who had been treated with type A botulinum toxin. The frequency of detectable ABT was 3% (three patients). Patients with ABT had received more than 50 ng of botulinum toxin, and the shortest time between two injections was significantly less than in patients without ABT. The clinical evolution of the three patients was heterogeneous: one had decreased effectiveness with repeated injections, another had persistent improvement, and the third never responded to toxin injections.
Comment in
-
Antibodies to botulinum toxin.Neurology. 1995 Jan;45(1):204. doi: 10.1212/wnl.45.1.204. Neurology. 1995. PMID: 7880304 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical